MDT

86.38

+0.14%↑

A

113.77

-0.97%↓

VEEV

172.52

-1.27%↓

HQY

80.96

-2.52%↓

TLRY

6.45

-2.86%↓

MDT

86.38

+0.14%↑

A

113.77

-0.97%↓

VEEV

172.52

-1.27%↓

HQY

80.96

-2.52%↓

TLRY

6.45

-2.86%↓

MDT

86.38

+0.14%↑

A

113.77

-0.97%↓

VEEV

172.52

-1.27%↓

HQY

80.96

-2.52%↓

TLRY

6.45

-2.86%↓

MDT

86.38

+0.14%↑

A

113.77

-0.97%↓

VEEV

172.52

-1.27%↓

HQY

80.96

-2.52%↓

TLRY

6.45

-2.86%↓

MDT

86.38

+0.14%↑

A

113.77

-0.97%↓

VEEV

172.52

-1.27%↓

HQY

80.96

-2.52%↓

TLRY

6.45

-2.86%↓

Search

Avita Therapeutics Inc

Chiusa

3.87 0.26

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

3.7800000000000002

Massimo

3.94

Metriche Chiave

By Trading Economics

Entrata

1.6M

-12M

Vendite

554K

18M

Margine di Profitto

-65.968

Dipendenti

226

EBITDA

1.6M

-9.7M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+62.31% upside

Dividendi

By Dow Jones

Utili prossimi

7 mag 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-4M

119M

Apertura precedente

3.61

Chiusura precedente

3.87

Punteggio Tecnico

By Trading Central

Fiducia

Very Strong Bearish Evidence

Avita Therapeutics Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

7 apr 2026, 17:26 UTC

Principali Notizie su Eventi

EIA Raises Oil-Price Forecasts as War in Middle East Continues

7 apr 2026, 23:55 UTC

Discorsi di Mercato

Genesis Energy Signals Higher Dividend Payout Ratios -- Market Talk

7 apr 2026, 23:47 UTC

Discorsi di Mercato
Principali Notizie su Eventi

Market Talk Roundup: Latest on U.S. Politics

7 apr 2026, 23:47 UTC

Discorsi di Mercato
Principali Notizie su Eventi

Precious Metals Rise, Boosted by Dollar Weakness, Lower Treasury Yields -- Market Talk

7 apr 2026, 23:44 UTC

Discorsi di Mercato
Principali Notizie su Eventi

Gold Rallies as Trump Remarks Send Oil Prices Lower -- Market Talk

7 apr 2026, 23:42 UTC

Discorsi di Mercato

Global Equities Roundup: Market Talk

7 apr 2026, 23:42 UTC

Discorsi di Mercato

Nikkei Likely to Rise After Trump Agrees to Cease-Fire With Iran -- Market Talk

7 apr 2026, 23:37 UTC

Discorsi di Mercato
Principali Notizie su Eventi

Oil Futures Fall After Trump Agrees to Two-Week Cease-Fire With Iran -- Market Talk

7 apr 2026, 23:15 UTC

Discorsi di Mercato
Principali Notizie su Eventi

Markets Will Want Fast Evidence That Ships Are Moving -- Market Talk

7 apr 2026, 23:04 UTC

Principali Notizie su Eventi

Spot Gold Rises 2.5%, Spot Silver Climbs 4.9%

7 apr 2026, 23:04 UTC

Principali Notizie su Eventi

Precious Metals Rise After Trump Agrees to Ceasefire With Iran

7 apr 2026, 23:03 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

7 apr 2026, 23:03 UTC

Discorsi di Mercato

Middle East Ceasefire Triggers Australian Dollar Rally -- Market Talk

7 apr 2026, 23:01 UTC

Principali Notizie su Eventi

Front-Month WTI Crude Oil Futures Falls 13.7% to $97.47 per Barrel

7 apr 2026, 22:58 UTC

Principali Notizie su Eventi

Front-Month Crude Oil Futures Slide After Trump Agrees to Cease-Fire With Iran

7 apr 2026, 21:56 UTC

Acquisizioni, Fusioni, Takeovers

Telefónica Sells All Shares in Pegaso PCS, Celular de Telefonía

7 apr 2026, 20:50 UTC

Discorsi di Mercato
Principali Notizie su Eventi

Basic Materials Roundup: Market Talk

7 apr 2026, 20:15 UTC

Discorsi di Mercato

Global Commodities Roundup: Market Talk

7 apr 2026, 19:45 UTC

Discorsi di Mercato

Treasury Yields Mixed as Investors Brace for Iran Deadline -- Market Talk

7 apr 2026, 19:17 UTC

Principali Notizie su Eventi

The Risks to the Gulf Region's Oil Are Immense. Are Markets Shrugging Them Off? -- Barrons.com

7 apr 2026, 19:16 UTC

Discorsi di Mercato

Cold Shot Helps U.S. Natural Gas Futures Settle Higher -- Market Talk

7 apr 2026, 19:07 UTC

Discorsi di Mercato

Global Energy Roundup: Market Talk

7 apr 2026, 19:07 UTC

Discorsi di Mercato

Oil Futures Mixed Ahead of Trump's Iran Deadline -- Market Talk

7 apr 2026, 18:41 UTC

Acquisizioni, Fusioni, Takeovers

Eldorado Gold: Total of 149.6M Common Shrs, Representing 75.31% of Votes Attached to All Outstanding Common Shrs, Were Voted >ELD.T

7 apr 2026, 18:40 UTC

Acquisizioni, Fusioni, Takeovers

Eldorado Gold Holders Voted to Approve Issuance of Common Shrs in Connection With Proposed Plan of Arrangement With Foran Mining >ELD.T

7 apr 2026, 18:39 UTC

Acquisizioni, Fusioni, Takeovers

Eldorado Gold Reports Voting Results From Special Meeting of Hldrs

7 apr 2026, 18:24 UTC

Principali Notizie su Eventi

Defense Stocks Can't Get a Boost From Iran War Escalations. What Would Move Them. -- Barrons.com

7 apr 2026, 17:08 UTC

Discorsi di Mercato

Latin America Less Exposed to Crude Supply Disruptions -- Market Talk

7 apr 2026, 16:21 UTC

Principali Notizie su Eventi

Defense Stocks Can't Get a Boost From Iran War Escalations. What Would Move Them. -- Barrons.com

7 apr 2026, 16:20 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

Health Care Roundup: Market Talk

Confronto tra pari

Modifica del prezzo

Avita Therapeutics Inc Previsione

Obiettivo di Prezzo

By TipRanks

62.31% in crescita

Previsioni per 12 mesi

Media 6.33 USD  62.31%

Alto 10 USD

Basso 3.5 USD

Basato su 4 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Avita Therapeutics Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

4 ratings

2

Acquista

2

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

8.83 / 9.77Supporto e resistenza

A breve termine

Very Strong Bearish Evidence

A termine intermedio

Bullish Evidence

A lungo termine

Weak Bearish Evidence

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Avita Therapeutics Inc

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.
help-icon Live chat